Novartis India today said it has received FIPB approval to sell its OTC division to GlaxoSmithKline Consumer Pvt Ltd (GSK CPL) and will now proceed to complete the transaction. The Foreign Investment Promotion Board (FIPB) has approved the proposal ... Business Standard, 1 day ago
Novartis India gets FIPB approval to sell OTC business to GSK CPL - India Infoline, 1 day ago
Novartis announced it will acquire all remaining rights to Ofatumumab from GlaxoSmithKline plc (GSK). Ofatumumab, a fully human monoclonal antibody which targets CD20, is being developed for relapsing remitting multiple sclerosis (RRMS) and other ...Pharmaceutical Manufacturing Magazine, 3 days ago Novartis pays $1 billion to bolster its pipeline with ofatumumab European Pharmaceutical Review, 4 days ago Novartis Acquires Rights to GSK's Ofatumumab Drug For Multiple Sclerosis Treatment MedIndia, 5 days ago Novartis buys GSK's antibody drug, Ofatumumab Bio Spectrum Asia, 1 week ago
Discuss pharmaceutical market access strategies with MSD, Sanofi and GSK | European Pharmaceutical Pricing & Reimbursement
London (PRWEB UK) 27 August 2015 SMi's 21st annual European Pharmaceutical Pricing & Reimbursement conference will provide the ideal platform for payers and other decision makers from both public and private organisations, to benchmark with ...PRWeb, 2 days ago GSK tasks PSN on continuous education for pharmacists The Guardian Nigeria, 2 weeks ago GSK Pharma to start operations at its Bengaluru facility by 2017 Finalaya.com, 3 weeks ago GSK also notes slowdown in China, but working on driving volumes Fierce Biotech Research, 3 weeks ago
Reddit Email Print Reprint SAN FRANCISCO , Aug. 27, 2015 /PRNewswire-USNewswire/ --QB3@953—a San Francisco incubator created by QB3, a University of California (UC) research institute and biotech accelerator— today announced an ...TheStreet.com, 2 days ago GSK enters research agreement with San Francisco incubator QB3@953 Pharma Letter, 2 days ago Five Prime Therapeutics Announces Oral Presentation Of Initial Data From Ongoing Phase 1b Trial Of FP-1039/GSK3052230 In Squamous Non Small Cell Lung Cancer And Mesothelioma At World Conference On Lung Cancer TheStreet.com, 5 days ago
SOURCE: GLAXOSMITHKLINE. In the pharmaceutical industry, GlaxoSmithKline ( NYSE:GSK ), the self-proclaimed "science-led global healthcare company", ranks among the largest companies by market capitalization. The London-based pharmaceutical giant ...Citybizlist, 5 days ago Dividend Investors Find the GlaxoSmithKline Yield Hard to Resist Motley Fool, 1 week ago Pfizer Is in Talks to Acquire GlaxoSmithKline Motley Fool, 2 weeks ago 3 Reasons GlaxoSmithKline Investors Can Breathe a Sigh of Relief Motley Fool, 3 weeks ago
More from: , Citybizlist...and 1 other sources
Do Results Make Hikma Pharmaceuticals Plc A Better Bet Than AstraZeneca plc And GlaxoSmithKline plc?
Who is the real competitor to AstraZeneca (LSE: AZN) and GlaxoSmithKline (LSE: GSK)? In an obvious way they're competing with each other and with the other major blockbuster drug researchers around the world. But it was a very different kind of ...Yahoo! UK and Ireland, 1 week ago 3 Reasons To Buy GlaxoSmithKline plc And Sell Quindell PLC Today Yahoo! UK and Ireland, 2 weeks ago Better Dividend Stock: GlaxoSmithKline plc vs. AstraZeneca plc Motley Fool, 2 weeks ago GlaxoSmithKline plc (ADR) (GSK) Stock Update - Takeover Rumors Drive Recent Gain Bidness Etc, 2 weeks ago
Over the past three years, India Inc's debt burden at the aggregate level has increased significantly without proportionate improvement in either topline or profits. Also, a weaker trend in the rupee against major currencies will make matters worse for ...Economic Times, 6 days ago
Neil Woodford is one of AstraZeneca (LSE: AZN) GlaxoSmithKline's (LSE: GSK) most vocal supporters. The star fund manager has sung the praises of Astra and Glaxo's management many times over, and he commended Astra's decision to turn down US drugs ...Yahoo! UK and Ireland, 1 week ago
- Karachi—After nearly 30 years of research and development, GSK's malaria candidate vaccine, Mosquirix (RTS,S), receives positive opinion from European regulators for the prevention of malaria. UK's drug giant GSK announced today that the ...Pakistan Observer, 1 week ago Dar awaits WHO approval on malaria vaccine Daily News TSN, 3 weeks ago
Regulatory Story GlaxoSmithKline PLC - GSK Released 12:19 03-Aug-2015 RNS Number : 8937U GlaxoSmithKline PLC 03 August 2015 GlaxoSmithKline plc Notification of Transactions of Directors and Persons Discharging Managerial Responsibilities or ...London Stock Exchange, 3 weeks ago Total Voting Rights London Stock Exchange, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!